Inventor · disambiguated record
In-Hyun Lee
Also filed as: LEE IN-HYUN
6 granted patents·17 pending applications·60 citations·filing 2002–2024
75Inventor score
Top patents by PatentIndex Score
23 records- 0190US8075917B2Composition for solubilization of paclitaxel and preparation method thereofCHUNG HESSON·Filed 2003·Granted Dec 13, 2011·58 cites·16 claims
- 0280US9768471B2Rechargeable lithium batterySAMSUNG SDI CO LTD·Filed 2015·Granted Sep 19, 2017·2 cites·7 claims
- 0368US2010041744A1Oily paclitaxel composition and formulation for chemoembolization and preparation method thereofDAEHWA PHARM CO LTD·Filed 2009·Application pending·0 cites
- 0459US2025289808A1Novel carboxamide redox derivative of inhibiting bet protein and composition for preventing and treating ophthalmic diseases using the sameBENOBIO CO LTD·Filed 2024·Application pending·0 cites
- 0559US2025289783A1Novel carboxamide redox derivative of inhibiting bet protein and composition for preventing and treating ophthalmic diseases using the sameBENOBIO CO LTD·Filed 2024·Application pending·0 cites
- 0657US2025221977A1Novel benzothiophene derivative and use thereof as bet inhibitorBENOBIO CO LTD·Filed 2023·Application pending·0 cites
- 0757US2025019335A1Novel quinizarin derivative and preparation method thereofBENOBIO CO LTD·Filed 2022·Application pending·0 cites
- 0856US11116744B2Pharmaceutical composition for oral administration comprising taxaneDAE HWA PHARMA CO LTD·Filed 2020·Granted Sep 14, 2021·0 cites·7 claims
- 0955US2010029755A1P-Glycoprotein inhibitor comprising octilonium bromide as an effective ingredientCHUNG HESSON·Filed 2009·Application pending·0 cites
- 1054US2017252453A9Transmucosal delivery of pharmaceutical active substancesANYGEN CO LTD·Filed 2014·Application pending·0 cites
- 1153US2004241094A1Oily paclitaxel composition and formulation for chemoembolization and preparation method thereofFiled 2002·Application pending·0 cites
- 1250US10653663B2Pharmaceutical composition for oral administration comprising taxaneDAE HWA PHARMA CO LTD·Filed 2015·Granted May 19, 2020·0 cites·4 claims
- 1349US2007292387A1Transmucosal delivery of pharmaceutical active substancesKWANGJU INST SCI & TECH·Filed 2007·Application pending·0 cites
- 1448US2023053152A1Novel Quercetin Redox Derivative And Use Thereof As BET InhibitorBENOBIO CO LTD·Filed 2020·Application pending·0 cites
- 1548US2006127420A1Paclitaxel composition for the intravesical treatment of bladder tumor and preparation method thereofCHUNG HESSON·Filed 2003·Application pending·0 cites
- 1645US2022296560A1Pharmaceutical composition for oral administration in powder formulation containing antiviral agentDAE HWA PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 1745US2006141033A1P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredientCHUNG HESSON·Filed 2003·Application pending·0 cites
- 1844US2020230099A1Stable Pharmaceutical Composition Comprising ZanamivirDAE HWA PHARMA CO LTD·Filed 2018·Application pending·0 cites
- 1943US2022313684A1Pharmaceutical composition comprising irinotecan free base for oral administrationDAE HWA PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 2043US2014141294A1Rechargeable batterySAMSUNG SDI CO LTD·Filed 2013·Application pending·0 cites
- 2139US11020370B2Pharmaceutical composition for oral administration comprising high concentration taxaneDAE HWA PHARMA CO LTD·Filed 2016·Granted Jun 1, 2021·0 cites·3 claims
- 2239US10987335B2Pharmaceutical composition for oral administration comprising high concentration taxaneDAE HWA PHARMA CO LTD·Filed 2016·Granted Apr 27, 2021·0 cites·15 claims
- 2339US2006134144A1Mucoadhesive composition and formulation for solubilization of insoluble drugs and preparation method thereofCHUNG HESSON·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →